Table of Contents
Bone Marrow Research
Volume 2014, Article ID 891427, 7 pages
http://dx.doi.org/10.1155/2014/891427
Clinical Study

Autologous Graft versus Host Disease: An Emerging Complication in Patients with Multiple Myeloma

1Division of Hematology and Oncology, Department of Medicine, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 508, Little Rock, AR 72205, USA
2Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 823, Little Rock, AR 72205, USA
3Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 502, Little Rock, AR 72205, USA

Received 21 February 2014; Accepted 2 April 2014; Published 4 May 2014

Academic Editor: Paolo De Fabritiis

Copyright © 2014 Anu Batra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. R. Drobyski, P. Hari, C. Keever-Taylor, R. Komorowski, and W. Grossman, “Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma,” Bone Marrow Transplantation, vol. 43, no. 2, pp. 169–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. H. M. Lazarus, S. R. Sommers, L. M. Arfons et al., “Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts,” Biology of Blood and Marrow Transplantation, vol. 17, no. 7, pp. 970–978, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Fidler, T. Klumpp, K. Mangan et al., “Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant,” American Journal of Hematology, vol. 87, no. 2, pp. 219–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Galustian, B. Meyer, M.-C. Labarthe et al., “The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells,” Cancer Immunology, Immunotherapy, vol. 58, no. 7, pp. 1033–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-H. Ling, L. Liebes, B. Ng et al., “PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis,” Molecular Cancer Therapeutics, vol. 1, no. 10, pp. 841–849, 2002. View at Google Scholar · View at Scopus
  6. T. Hideshima, P. Richardson, D. Chauhan et al., “The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells,” Cancer Research, vol. 61, no. 7, pp. 3071–3076, 2001. View at Google Scholar · View at Scopus
  7. K. M. Dhodapkar, S. Barbuto, P. Matthews et al., “Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma,” Blood, vol. 112, no. 7, pp. 2878–2885, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. H. Kim, W. W. Greenfield, M. J. Cannon, H. N. Coleman, H. J. Spencer, and M. Nakagawa, “CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend,” Cancer Immunology, Immunotherapy, vol. 61, no. 1, pp. 63–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Harville, “HLA typing for cellular product characterization and identity testing,” in Cellular Therapy: Principles, Methods, and Regulations, E. M. Areman and K. Loper, Eds., pp. 627–643, AABB, Bethesda, Md, USA, 2009. View at Google Scholar
  10. Organ Procurement and Transplantation Network, US Department of Health & Human Services.
  11. F. Ishikawa, H. Shigematsu, H. Gondo, T. Okamura, and Y. Niho, “Autoreactive antibodies following autologous peripheral blood stem cell transplantation,” Bone Marrow Transplantation, vol. 22, no. 7, pp. 729–731, 1998. View at Google Scholar · View at Scopus
  12. I. Isshiki, S. Okamoto, T. Kakimoto et al., “Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma,” International Journal of Hematology, vol. 84, no. 4, pp. 354–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Z. Orlowski, T. E. Stinchcombe, B. S. Mitchell et al., “Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies,” Journal of Clinical Oncology, vol. 20, no. 22, pp. 4420–4427, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Ahmad, K. Haider, and R. Kanthan, “Autoimmune thrombocytopenia following tandem autologous peripheral blood stem cell transplantation for refractory germ cell tumor,” Bone Marrow Transplantation, vol. 34, no. 3, pp. 279–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Lambertenghi-Deliliers, C. Annaloro, A. della Volpe, A. Oriani, E. Pozzoli, and D. Soligo, “Multiple autoimmune events after autologous bone marrow transplantation,” Bone Marrow Transplantation, vol. 19, no. 7, pp. 745–747, 1997. View at Google Scholar · View at Scopus
  16. K. Briegel, K.-C. Lim, C. Plank, H. Beug, J. D. Engel, and M. Zenke, “Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner,” Genes & Development, vol. 7, no. 6, pp. 1097–1109, 1993. View at Google Scholar · View at Scopus
  17. R. Benjamin and P. Parham, “Guilt by association: HLA-B27 and ankylosing spondylitis,” Immunology Today, vol. 11, no. 4, pp. 137–142, 1990. View at Google Scholar · View at Scopus
  18. R. A. Colbert, “HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?” Molecular Medicine Today, vol. 6, no. 6, pp. 224–230, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Colbert, T. M. Tran, and G. Layh-Schmitt, “HLA-B27 misfolding and ankylosing spondylitis,” Molecular Immunology, vol. 57, no. 1, pp. 44–51, 2014. View at Publisher · View at Google Scholar
  20. J. C. W. Edwards, P. Bowness, and J. R. Archer, “Jekyll and Hyde: the transformation of HLA-B27,” Immunology Today, vol. 21, no. 6, pp. 256–260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Marsh, P. Parham, and L. Barber, The HLA FactsBook, Academic Press, New York, NY, USA, 2000.